Lumexa Imaging (NASDAQ:LMRI) Shares Down 5.8% – Time to Sell?

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) shares dropped 5.8% during mid-day trading on Monday . The stock traded as low as $7.99 and last traded at $8.0050. Approximately 572,659 shares traded hands during trading, a decline of 34% from the average daily volume of 865,049 shares. The stock had previously closed at $8.50.

Analyst Upgrades and Downgrades

LMRI has been the topic of several research analyst reports. Weiss Ratings upgraded Lumexa Imaging from a “sell (e-)” rating to a “sell (e)” rating in a research note on Monday, June 1st. Raymond James Financial raised Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 target price on the stock in a research report on Monday, February 9th. Finally, Barclays dropped their target price on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $16.00.

Lumexa Imaging Stock Down 4.4%

The stock’s 50 day moving average price is $8.78.

Insiders Place Their Bets

In other news, Director Brett Brodnax bought 35,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 19th. The stock was acquired at an average price of $7.25 per share, with a total value of $253,750.00. Following the completion of the purchase, the director directly owned 62,027 shares of the company’s stock, valued at $449,695.75. This represents a 129.50% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. 0.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Lumexa Imaging

Several institutional investors have recently made changes to their positions in the company. Assetmark Inc. acquired a new stake in shares of Lumexa Imaging during the 4th quarter valued at about $36,000. Strs Ohio acquired a new stake in shares of Lumexa Imaging during the 1st quarter valued at about $38,000. Barclays PLC acquired a new stake in shares of Lumexa Imaging during the 4th quarter valued at about $133,000. PNC Financial Services Group Inc. acquired a new stake in shares of Lumexa Imaging during the 1st quarter valued at about $63,000. Finally, Principal Financial Group Inc. lifted its holdings in shares of Lumexa Imaging by 1.2% during the 1st quarter. Principal Financial Group Inc. now owns 664,136 shares of the company’s stock valued at $5,712,000 after buying an additional 7,875 shares during the last quarter.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).